Hmmm...
So let's take them at face value here and assume that the first debt repayment is only $7M. That leaves $24M for them to find between Jan and Jun to clear the total of ~31M due by June 30.
Also (by my read) they are saying that they are going to make 8-18M for this quarter in net total cashflow after all outgoings, despite losing 1M for the prior quarter at a similar production rate...(those poor, poor creditors).
Also, how (with less then 2 months to go) is the range that wide?? It implies they have either run down inventories or hit an unusually high grade section that they are not confident of sustaining to have a a greater than 125% difference between the top of the range and the bottom.
This smacks of a positive news announcement prior to a raise under the guise of "modest" capital expenditure designed to shift throughout from 1.3M to 1.5M. In reality it will likely be used to support cashflow which (probably) won't materialise in the next 2 months. I'm scaling back the size of the raise though. Reckon they will try to sneak a little 5M one in this year and then similar to slightly larger again on or around June '24.
- Forums
- ASX - By Stock
- G1A
- Ann: Abra Production and Operations Update
Ann: Abra Production and Operations Update, page-3
Featured News
Add G1A (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.40M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
G1A (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online